Global RNAi Drugs Market Research Report 2024(Status and Outlook)
Report Overview
It refers to the highly conservative, double stranded RNA induced, highly specific degradation of homologous mRNA in the evolutionary process
This report provides a deep insight into the global RNAi Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNAi Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNAi Drugs market in any manner.
Global RNAi Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam
Novo Nordisk
Eli Lilly
Alexion
Novartis
Roche
Arrowhead Pharmaceuticals Inc.
CureVac AG
Dicerna Pharmaceuticals Inc.
Gradalis Inc.
Ionis Pharmaceuticals Inc
Merck & Co. Inc.
Moderna Inc.
SBI ALApharma
Silence Therapeutics Plc
Sirnaomics Inc.
Market Segmentation (by Type)
siRNA
shRNA
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNAi Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
It refers to the highly conservative, double stranded RNA induced, highly specific degradation of homologous mRNA in the evolutionary process
This report provides a deep insight into the global RNAi Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNAi Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNAi Drugs market in any manner.
Global RNAi Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam
Novo Nordisk
Eli Lilly
Alexion
Novartis
Roche
Arrowhead Pharmaceuticals Inc.
CureVac AG
Dicerna Pharmaceuticals Inc.
Gradalis Inc.
Ionis Pharmaceuticals Inc
Merck & Co. Inc.
Moderna Inc.
SBI ALApharma
Silence Therapeutics Plc
Sirnaomics Inc.
Market Segmentation (by Type)
siRNA
shRNA
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the RNAi Drugs Market
- Overview of the regional outlook of the RNAi Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNAi Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of RNAi Drugs
1.2 Key Market Segments
1.2.1 RNAi Drugs Segment by Type
1.2.2 RNAi Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNAI DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNAi Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNAi Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNAI DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global RNAi Drugs Sales by Manufacturers (2019-2024)
3.2 Global RNAi Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 RNAi Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNAi Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNAi Drugs Sales Sites, Area Served, Product Type
3.6 RNAi Drugs Market Competitive Situation and Trends
3.6.1 RNAi Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNAi Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNAI DRUGS INDUSTRY CHAIN ANALYSIS
4.1 RNAi Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNAI DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNAI DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNAi Drugs Sales Market Share by Type (2019-2024)
6.3 Global RNAi Drugs Market Size Market Share by Type (2019-2024)
6.4 Global RNAi Drugs Price by Type (2019-2024)
7 RNAI DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNAi Drugs Market Sales by Application (2019-2024)
7.3 Global RNAi Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
8 RNAI DRUGS MARKET SEGMENTATION BY REGION
8.1 Global RNAi Drugs Sales by Region
8.1.1 Global RNAi Drugs Sales by Region
8.1.2 Global RNAi Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America RNAi Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNAi Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNAi Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNAi Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNAi Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam
9.1.1 Alnylam RNAi Drugs Basic Information
9.1.2 Alnylam RNAi Drugs Product Overview
9.1.3 Alnylam RNAi Drugs Product Market Performance
9.1.4 Alnylam Business Overview
9.1.5 Alnylam RNAi Drugs SWOT Analysis
9.1.6 Alnylam Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk RNAi Drugs Basic Information
9.2.2 Novo Nordisk RNAi Drugs Product Overview
9.2.3 Novo Nordisk RNAi Drugs Product Market Performance
9.2.4 Novo Nordisk Business Overview
9.2.5 Novo Nordisk RNAi Drugs SWOT Analysis
9.2.6 Novo Nordisk Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly RNAi Drugs Basic Information
9.3.2 Eli Lilly RNAi Drugs Product Overview
9.3.3 Eli Lilly RNAi Drugs Product Market Performance
9.3.4 Eli Lilly RNAi Drugs SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Alexion
9.4.1 Alexion RNAi Drugs Basic Information
9.4.2 Alexion RNAi Drugs Product Overview
9.4.3 Alexion RNAi Drugs Product Market Performance
9.4.4 Alexion Business Overview
9.4.5 Alexion Recent Developments
9.5 Novartis
9.5.1 Novartis RNAi Drugs Basic Information
9.5.2 Novartis RNAi Drugs Product Overview
9.5.3 Novartis RNAi Drugs Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Roche
9.6.1 Roche RNAi Drugs Basic Information
9.6.2 Roche RNAi Drugs Product Overview
9.6.3 Roche RNAi Drugs Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Arrowhead Pharmaceuticals Inc.
9.7.1 Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
9.7.2 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
9.7.3 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Market Performance
9.7.4 Arrowhead Pharmaceuticals Inc. Business Overview
9.7.5 Arrowhead Pharmaceuticals Inc. Recent Developments
9.8 CureVac AG
9.8.1 CureVac AG RNAi Drugs Basic Information
9.8.2 CureVac AG RNAi Drugs Product Overview
9.8.3 CureVac AG RNAi Drugs Product Market Performance
9.8.4 CureVac AG Business Overview
9.8.5 CureVac AG Recent Developments
9.9 Dicerna Pharmaceuticals Inc.
9.9.1 Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
9.9.2 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
9.9.3 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Market Performance
9.9.4 Dicerna Pharmaceuticals Inc. Business Overview
9.9.5 Dicerna Pharmaceuticals Inc. Recent Developments
9.10 Gradalis Inc.
9.10.1 Gradalis Inc. RNAi Drugs Basic Information
9.10.2 Gradalis Inc. RNAi Drugs Product Overview
9.10.3 Gradalis Inc. RNAi Drugs Product Market Performance
9.10.4 Gradalis Inc. Business Overview
9.10.5 Gradalis Inc. Recent Developments
9.11 Ionis Pharmaceuticals Inc
9.11.1 Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
9.11.2 Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
9.11.3 Ionis Pharmaceuticals Inc RNAi Drugs Product Market Performance
9.11.4 Ionis Pharmaceuticals Inc Business Overview
9.11.5 Ionis Pharmaceuticals Inc Recent Developments
9.12 Merck and Co. Inc.
9.12.1 Merck and Co. Inc. RNAi Drugs Basic Information
9.12.2 Merck and Co. Inc. RNAi Drugs Product Overview
9.12.3 Merck and Co. Inc. RNAi Drugs Product Market Performance
9.12.4 Merck and Co. Inc. Business Overview
9.12.5 Merck and Co. Inc. Recent Developments
9.13 Moderna Inc.
9.13.1 Moderna Inc. RNAi Drugs Basic Information
9.13.2 Moderna Inc. RNAi Drugs Product Overview
9.13.3 Moderna Inc. RNAi Drugs Product Market Performance
9.13.4 Moderna Inc. Business Overview
9.13.5 Moderna Inc. Recent Developments
9.14 SBI ALApharma
9.14.1 SBI ALApharma RNAi Drugs Basic Information
9.14.2 SBI ALApharma RNAi Drugs Product Overview
9.14.3 SBI ALApharma RNAi Drugs Product Market Performance
9.14.4 SBI ALApharma Business Overview
9.14.5 SBI ALApharma Recent Developments
9.15 Silence Therapeutics Plc
9.15.1 Silence Therapeutics Plc RNAi Drugs Basic Information
9.15.2 Silence Therapeutics Plc RNAi Drugs Product Overview
9.15.3 Silence Therapeutics Plc RNAi Drugs Product Market Performance
9.15.4 Silence Therapeutics Plc Business Overview
9.15.5 Silence Therapeutics Plc Recent Developments
9.16 Sirnaomics Inc.
9.16.1 Sirnaomics Inc. RNAi Drugs Basic Information
9.16.2 Sirnaomics Inc. RNAi Drugs Product Overview
9.16.3 Sirnaomics Inc. RNAi Drugs Product Market Performance
9.16.4 Sirnaomics Inc. Business Overview
9.16.5 Sirnaomics Inc. Recent Developments
10 RNAI DRUGS MARKET FORECAST BY REGION
10.1 Global RNAi Drugs Market Size Forecast
10.2 Global RNAi Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNAi Drugs Market Size Forecast by Country
10.2.3 Asia Pacific RNAi Drugs Market Size Forecast by Region
10.2.4 South America RNAi Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNAi Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNAi Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNAi Drugs by Type (2025-2030)
11.1.2 Global RNAi Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNAi Drugs by Type (2025-2030)
11.2 Global RNAi Drugs Market Forecast by Application (2025-2030)
11.2.1 Global RNAi Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global RNAi Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of RNAi Drugs
1.2 Key Market Segments
1.2.1 RNAi Drugs Segment by Type
1.2.2 RNAi Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNAI DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNAi Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNAi Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNAI DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global RNAi Drugs Sales by Manufacturers (2019-2024)
3.2 Global RNAi Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 RNAi Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNAi Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNAi Drugs Sales Sites, Area Served, Product Type
3.6 RNAi Drugs Market Competitive Situation and Trends
3.6.1 RNAi Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNAi Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNAI DRUGS INDUSTRY CHAIN ANALYSIS
4.1 RNAi Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNAI DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNAI DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNAi Drugs Sales Market Share by Type (2019-2024)
6.3 Global RNAi Drugs Market Size Market Share by Type (2019-2024)
6.4 Global RNAi Drugs Price by Type (2019-2024)
7 RNAI DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNAi Drugs Market Sales by Application (2019-2024)
7.3 Global RNAi Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
8 RNAI DRUGS MARKET SEGMENTATION BY REGION
8.1 Global RNAi Drugs Sales by Region
8.1.1 Global RNAi Drugs Sales by Region
8.1.2 Global RNAi Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America RNAi Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNAi Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNAi Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNAi Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNAi Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam
9.1.1 Alnylam RNAi Drugs Basic Information
9.1.2 Alnylam RNAi Drugs Product Overview
9.1.3 Alnylam RNAi Drugs Product Market Performance
9.1.4 Alnylam Business Overview
9.1.5 Alnylam RNAi Drugs SWOT Analysis
9.1.6 Alnylam Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk RNAi Drugs Basic Information
9.2.2 Novo Nordisk RNAi Drugs Product Overview
9.2.3 Novo Nordisk RNAi Drugs Product Market Performance
9.2.4 Novo Nordisk Business Overview
9.2.5 Novo Nordisk RNAi Drugs SWOT Analysis
9.2.6 Novo Nordisk Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly RNAi Drugs Basic Information
9.3.2 Eli Lilly RNAi Drugs Product Overview
9.3.3 Eli Lilly RNAi Drugs Product Market Performance
9.3.4 Eli Lilly RNAi Drugs SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Alexion
9.4.1 Alexion RNAi Drugs Basic Information
9.4.2 Alexion RNAi Drugs Product Overview
9.4.3 Alexion RNAi Drugs Product Market Performance
9.4.4 Alexion Business Overview
9.4.5 Alexion Recent Developments
9.5 Novartis
9.5.1 Novartis RNAi Drugs Basic Information
9.5.2 Novartis RNAi Drugs Product Overview
9.5.3 Novartis RNAi Drugs Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Roche
9.6.1 Roche RNAi Drugs Basic Information
9.6.2 Roche RNAi Drugs Product Overview
9.6.3 Roche RNAi Drugs Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Arrowhead Pharmaceuticals Inc.
9.7.1 Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
9.7.2 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
9.7.3 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Market Performance
9.7.4 Arrowhead Pharmaceuticals Inc. Business Overview
9.7.5 Arrowhead Pharmaceuticals Inc. Recent Developments
9.8 CureVac AG
9.8.1 CureVac AG RNAi Drugs Basic Information
9.8.2 CureVac AG RNAi Drugs Product Overview
9.8.3 CureVac AG RNAi Drugs Product Market Performance
9.8.4 CureVac AG Business Overview
9.8.5 CureVac AG Recent Developments
9.9 Dicerna Pharmaceuticals Inc.
9.9.1 Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
9.9.2 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
9.9.3 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Market Performance
9.9.4 Dicerna Pharmaceuticals Inc. Business Overview
9.9.5 Dicerna Pharmaceuticals Inc. Recent Developments
9.10 Gradalis Inc.
9.10.1 Gradalis Inc. RNAi Drugs Basic Information
9.10.2 Gradalis Inc. RNAi Drugs Product Overview
9.10.3 Gradalis Inc. RNAi Drugs Product Market Performance
9.10.4 Gradalis Inc. Business Overview
9.10.5 Gradalis Inc. Recent Developments
9.11 Ionis Pharmaceuticals Inc
9.11.1 Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
9.11.2 Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
9.11.3 Ionis Pharmaceuticals Inc RNAi Drugs Product Market Performance
9.11.4 Ionis Pharmaceuticals Inc Business Overview
9.11.5 Ionis Pharmaceuticals Inc Recent Developments
9.12 Merck and Co. Inc.
9.12.1 Merck and Co. Inc. RNAi Drugs Basic Information
9.12.2 Merck and Co. Inc. RNAi Drugs Product Overview
9.12.3 Merck and Co. Inc. RNAi Drugs Product Market Performance
9.12.4 Merck and Co. Inc. Business Overview
9.12.5 Merck and Co. Inc. Recent Developments
9.13 Moderna Inc.
9.13.1 Moderna Inc. RNAi Drugs Basic Information
9.13.2 Moderna Inc. RNAi Drugs Product Overview
9.13.3 Moderna Inc. RNAi Drugs Product Market Performance
9.13.4 Moderna Inc. Business Overview
9.13.5 Moderna Inc. Recent Developments
9.14 SBI ALApharma
9.14.1 SBI ALApharma RNAi Drugs Basic Information
9.14.2 SBI ALApharma RNAi Drugs Product Overview
9.14.3 SBI ALApharma RNAi Drugs Product Market Performance
9.14.4 SBI ALApharma Business Overview
9.14.5 SBI ALApharma Recent Developments
9.15 Silence Therapeutics Plc
9.15.1 Silence Therapeutics Plc RNAi Drugs Basic Information
9.15.2 Silence Therapeutics Plc RNAi Drugs Product Overview
9.15.3 Silence Therapeutics Plc RNAi Drugs Product Market Performance
9.15.4 Silence Therapeutics Plc Business Overview
9.15.5 Silence Therapeutics Plc Recent Developments
9.16 Sirnaomics Inc.
9.16.1 Sirnaomics Inc. RNAi Drugs Basic Information
9.16.2 Sirnaomics Inc. RNAi Drugs Product Overview
9.16.3 Sirnaomics Inc. RNAi Drugs Product Market Performance
9.16.4 Sirnaomics Inc. Business Overview
9.16.5 Sirnaomics Inc. Recent Developments
10 RNAI DRUGS MARKET FORECAST BY REGION
10.1 Global RNAi Drugs Market Size Forecast
10.2 Global RNAi Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNAi Drugs Market Size Forecast by Country
10.2.3 Asia Pacific RNAi Drugs Market Size Forecast by Region
10.2.4 South America RNAi Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNAi Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNAi Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNAi Drugs by Type (2025-2030)
11.1.2 Global RNAi Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNAi Drugs by Type (2025-2030)
11.2 Global RNAi Drugs Market Forecast by Application (2025-2030)
11.2.1 Global RNAi Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global RNAi Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNAi Drugs Market Size Comparison by Region (M USD)
Table 5. Global RNAi Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global RNAi Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNAi Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNAi Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Drugs as of 2022)
Table 10. Global Market RNAi Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNAi Drugs Sales Sites and Area Served
Table 12. Manufacturers RNAi Drugs Product Type
Table 13. Global RNAi Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNAi Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNAi Drugs Market Challenges
Table 22. Global RNAi Drugs Sales by Type (Kilotons)
Table 23. Global RNAi Drugs Market Size by Type (M USD)
Table 24. Global RNAi Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global RNAi Drugs Sales Market Share by Type (2019-2024)
Table 26. Global RNAi Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global RNAi Drugs Market Size Share by Type (2019-2024)
Table 28. Global RNAi Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global RNAi Drugs Sales (Kilotons) by Application
Table 30. Global RNAi Drugs Market Size by Application
Table 31. Global RNAi Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global RNAi Drugs Sales Market Share by Application (2019-2024)
Table 33. Global RNAi Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global RNAi Drugs Market Share by Application (2019-2024)
Table 35. Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global RNAi Drugs Sales Market Share by Region (2019-2024)
Table 38. North America RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam RNAi Drugs Basic Information
Table 44. Alnylam RNAi Drugs Product Overview
Table 45. Alnylam RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Business Overview
Table 47. Alnylam RNAi Drugs SWOT Analysis
Table 48. Alnylam Recent Developments
Table 49. Novo Nordisk RNAi Drugs Basic Information
Table 50. Novo Nordisk RNAi Drugs Product Overview
Table 51. Novo Nordisk RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk RNAi Drugs SWOT Analysis
Table 54. Novo Nordisk Recent Developments
Table 55. Eli Lilly RNAi Drugs Basic Information
Table 56. Eli Lilly RNAi Drugs Product Overview
Table 57. Eli Lilly RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly RNAi Drugs SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Alexion RNAi Drugs Basic Information
Table 62. Alexion RNAi Drugs Product Overview
Table 63. Alexion RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Alexion Business Overview
Table 65. Alexion Recent Developments
Table 66. Novartis RNAi Drugs Basic Information
Table 67. Novartis RNAi Drugs Product Overview
Table 68. Novartis RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Roche RNAi Drugs Basic Information
Table 72. Roche RNAi Drugs Product Overview
Table 73. Roche RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 77. Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 78. Arrowhead Pharmaceuticals Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Arrowhead Pharmaceuticals Inc. Business Overview
Table 80. Arrowhead Pharmaceuticals Inc. Recent Developments
Table 81. CureVac AG RNAi Drugs Basic Information
Table 82. CureVac AG RNAi Drugs Product Overview
Table 83. CureVac AG RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CureVac AG Business Overview
Table 85. CureVac AG Recent Developments
Table 86. Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 87. Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 88. Dicerna Pharmaceuticals Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Dicerna Pharmaceuticals Inc. Business Overview
Table 90. Dicerna Pharmaceuticals Inc. Recent Developments
Table 91. Gradalis Inc. RNAi Drugs Basic Information
Table 92. Gradalis Inc. RNAi Drugs Product Overview
Table 93. Gradalis Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Gradalis Inc. Business Overview
Table 95. Gradalis Inc. Recent Developments
Table 96. Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
Table 97. Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
Table 98. Ionis Pharmaceuticals Inc RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Ionis Pharmaceuticals Inc Business Overview
Table 100. Ionis Pharmaceuticals Inc Recent Developments
Table 101. Merck and Co. Inc. RNAi Drugs Basic Information
Table 102. Merck and Co. Inc. RNAi Drugs Product Overview
Table 103. Merck and Co. Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Merck and Co. Inc. Business Overview
Table 105. Merck and Co. Inc. Recent Developments
Table 106. Moderna Inc. RNAi Drugs Basic Information
Table 107. Moderna Inc. RNAi Drugs Product Overview
Table 108. Moderna Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Moderna Inc. Business Overview
Table 110. Moderna Inc. Recent Developments
Table 111. SBI ALApharma RNAi Drugs Basic Information
Table 112. SBI ALApharma RNAi Drugs Product Overview
Table 113. SBI ALApharma RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. SBI ALApharma Business Overview
Table 115. SBI ALApharma Recent Developments
Table 116. Silence Therapeutics Plc RNAi Drugs Basic Information
Table 117. Silence Therapeutics Plc RNAi Drugs Product Overview
Table 118. Silence Therapeutics Plc RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Silence Therapeutics Plc Business Overview
Table 120. Silence Therapeutics Plc Recent Developments
Table 121. Sirnaomics Inc. RNAi Drugs Basic Information
Table 122. Sirnaomics Inc. RNAi Drugs Product Overview
Table 123. Sirnaomics Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Sirnaomics Inc. Business Overview
Table 125. Sirnaomics Inc. Recent Developments
Table 126. Global RNAi Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global RNAi Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific RNAi Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific RNAi Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa RNAi Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global RNAi Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global RNAi Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global RNAi Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global RNAi Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global RNAi Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNAi Drugs Market Size Comparison by Region (M USD)
Table 5. Global RNAi Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global RNAi Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNAi Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNAi Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Drugs as of 2022)
Table 10. Global Market RNAi Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNAi Drugs Sales Sites and Area Served
Table 12. Manufacturers RNAi Drugs Product Type
Table 13. Global RNAi Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNAi Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNAi Drugs Market Challenges
Table 22. Global RNAi Drugs Sales by Type (Kilotons)
Table 23. Global RNAi Drugs Market Size by Type (M USD)
Table 24. Global RNAi Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global RNAi Drugs Sales Market Share by Type (2019-2024)
Table 26. Global RNAi Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global RNAi Drugs Market Size Share by Type (2019-2024)
Table 28. Global RNAi Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global RNAi Drugs Sales (Kilotons) by Application
Table 30. Global RNAi Drugs Market Size by Application
Table 31. Global RNAi Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global RNAi Drugs Sales Market Share by Application (2019-2024)
Table 33. Global RNAi Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global RNAi Drugs Market Share by Application (2019-2024)
Table 35. Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global RNAi Drugs Sales Market Share by Region (2019-2024)
Table 38. North America RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America RNAi Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa RNAi Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam RNAi Drugs Basic Information
Table 44. Alnylam RNAi Drugs Product Overview
Table 45. Alnylam RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Business Overview
Table 47. Alnylam RNAi Drugs SWOT Analysis
Table 48. Alnylam Recent Developments
Table 49. Novo Nordisk RNAi Drugs Basic Information
Table 50. Novo Nordisk RNAi Drugs Product Overview
Table 51. Novo Nordisk RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk RNAi Drugs SWOT Analysis
Table 54. Novo Nordisk Recent Developments
Table 55. Eli Lilly RNAi Drugs Basic Information
Table 56. Eli Lilly RNAi Drugs Product Overview
Table 57. Eli Lilly RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly RNAi Drugs SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Alexion RNAi Drugs Basic Information
Table 62. Alexion RNAi Drugs Product Overview
Table 63. Alexion RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Alexion Business Overview
Table 65. Alexion Recent Developments
Table 66. Novartis RNAi Drugs Basic Information
Table 67. Novartis RNAi Drugs Product Overview
Table 68. Novartis RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Roche RNAi Drugs Basic Information
Table 72. Roche RNAi Drugs Product Overview
Table 73. Roche RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 77. Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 78. Arrowhead Pharmaceuticals Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Arrowhead Pharmaceuticals Inc. Business Overview
Table 80. Arrowhead Pharmaceuticals Inc. Recent Developments
Table 81. CureVac AG RNAi Drugs Basic Information
Table 82. CureVac AG RNAi Drugs Product Overview
Table 83. CureVac AG RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CureVac AG Business Overview
Table 85. CureVac AG Recent Developments
Table 86. Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 87. Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 88. Dicerna Pharmaceuticals Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Dicerna Pharmaceuticals Inc. Business Overview
Table 90. Dicerna Pharmaceuticals Inc. Recent Developments
Table 91. Gradalis Inc. RNAi Drugs Basic Information
Table 92. Gradalis Inc. RNAi Drugs Product Overview
Table 93. Gradalis Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Gradalis Inc. Business Overview
Table 95. Gradalis Inc. Recent Developments
Table 96. Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
Table 97. Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
Table 98. Ionis Pharmaceuticals Inc RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Ionis Pharmaceuticals Inc Business Overview
Table 100. Ionis Pharmaceuticals Inc Recent Developments
Table 101. Merck and Co. Inc. RNAi Drugs Basic Information
Table 102. Merck and Co. Inc. RNAi Drugs Product Overview
Table 103. Merck and Co. Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Merck and Co. Inc. Business Overview
Table 105. Merck and Co. Inc. Recent Developments
Table 106. Moderna Inc. RNAi Drugs Basic Information
Table 107. Moderna Inc. RNAi Drugs Product Overview
Table 108. Moderna Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Moderna Inc. Business Overview
Table 110. Moderna Inc. Recent Developments
Table 111. SBI ALApharma RNAi Drugs Basic Information
Table 112. SBI ALApharma RNAi Drugs Product Overview
Table 113. SBI ALApharma RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. SBI ALApharma Business Overview
Table 115. SBI ALApharma Recent Developments
Table 116. Silence Therapeutics Plc RNAi Drugs Basic Information
Table 117. Silence Therapeutics Plc RNAi Drugs Product Overview
Table 118. Silence Therapeutics Plc RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Silence Therapeutics Plc Business Overview
Table 120. Silence Therapeutics Plc Recent Developments
Table 121. Sirnaomics Inc. RNAi Drugs Basic Information
Table 122. Sirnaomics Inc. RNAi Drugs Product Overview
Table 123. Sirnaomics Inc. RNAi Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Sirnaomics Inc. Business Overview
Table 125. Sirnaomics Inc. Recent Developments
Table 126. Global RNAi Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global RNAi Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific RNAi Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific RNAi Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America RNAi Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa RNAi Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa RNAi Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global RNAi Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global RNAi Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global RNAi Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global RNAi Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global RNAi Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of RNAi Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNAi Drugs Market Size (M USD), 2019-2030
Figure 5. Global RNAi Drugs Market Size (M USD) (2019-2030)
Figure 6. Global RNAi Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNAi Drugs Market Size by Country (M USD)
Figure 11. RNAi Drugs Sales Share by Manufacturers in 2023
Figure 12. Global RNAi Drugs Revenue Share by Manufacturers in 2023
Figure 13. RNAi Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNAi Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNAi Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNAi Drugs Market Share by Type
Figure 18. Sales Market Share of RNAi Drugs by Type (2019-2024)
Figure 19. Sales Market Share of RNAi Drugs by Type in 2023
Figure 20. Market Size Share of RNAi Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of RNAi Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNAi Drugs Market Share by Application
Figure 24. Global RNAi Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global RNAi Drugs Sales Market Share by Application in 2023
Figure 26. Global RNAi Drugs Market Share by Application (2019-2024)
Figure 27. Global RNAi Drugs Market Share by Application in 2023
Figure 28. Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNAi Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America RNAi Drugs Sales Market Share by Country in 2023
Figure 32. U.S. RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada RNAi Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico RNAi Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe RNAi Drugs Sales Market Share by Country in 2023
Figure 37. Germany RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific RNAi Drugs Sales Market Share by Region in 2023
Figure 44. China RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America RNAi Drugs Sales Market Share by Country in 2023
Figure 51. Brazil RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa RNAi Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global RNAi Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global RNAi Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNAi Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNAi Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global RNAi Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global RNAi Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of RNAi Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNAi Drugs Market Size (M USD), 2019-2030
Figure 5. Global RNAi Drugs Market Size (M USD) (2019-2030)
Figure 6. Global RNAi Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNAi Drugs Market Size by Country (M USD)
Figure 11. RNAi Drugs Sales Share by Manufacturers in 2023
Figure 12. Global RNAi Drugs Revenue Share by Manufacturers in 2023
Figure 13. RNAi Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNAi Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNAi Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNAi Drugs Market Share by Type
Figure 18. Sales Market Share of RNAi Drugs by Type (2019-2024)
Figure 19. Sales Market Share of RNAi Drugs by Type in 2023
Figure 20. Market Size Share of RNAi Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of RNAi Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNAi Drugs Market Share by Application
Figure 24. Global RNAi Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global RNAi Drugs Sales Market Share by Application in 2023
Figure 26. Global RNAi Drugs Market Share by Application (2019-2024)
Figure 27. Global RNAi Drugs Market Share by Application in 2023
Figure 28. Global RNAi Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNAi Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America RNAi Drugs Sales Market Share by Country in 2023
Figure 32. U.S. RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada RNAi Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico RNAi Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe RNAi Drugs Sales Market Share by Country in 2023
Figure 37. Germany RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific RNAi Drugs Sales Market Share by Region in 2023
Figure 44. China RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America RNAi Drugs Sales Market Share by Country in 2023
Figure 51. Brazil RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa RNAi Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa RNAi Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa RNAi Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global RNAi Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global RNAi Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNAi Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNAi Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global RNAi Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global RNAi Drugs Market Share Forecast by Application (2025-2030)
